Skip to menu Skip to content Skip to footer

2007

Conference Publication

Ferroportin : Membrane topologyand characterisation of mutations

Wallace, D. F. and Subramaniam, V. N. (2007). Ferroportin : Membrane topologyand characterisation of mutations. International BioIron Society Meeting, Kyoto, Japan, 1-6 April 2007. Hoboken, NJ, United States: John Wiley & Sons, Inc.. doi: 10.1002/ajh.20964

Ferroportin : Membrane topologyand characterisation of mutations

2006

Conference Publication

Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasis

Wallace, D. F., Summerville, L. and Subramaniam, V. N. (2006). Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasis. OXFORD: BLACKWELL PUBLISHING.

Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasis

2006

Conference Publication

Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasis

Wallace, D. F., Summerville, L. and Subramaniam, V. N. (2006). Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasis. Australian Gastroenterology Week, Adelaide, SA, Australia, 11-14 October 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Liver-specific deletion of the transferrin receptor 2 gene causes iron overload implicating the liver in regulation of iron homeostasis

2006

Conference Publication

The clinical relevance of compound heterozygosity for the haemochromatosis mutations (C282Y/H63D)

Walsh, A., Dixon, J. L., Ranun, G. A., Hewett, D. G., Lincoln, D., Anderson, G. L., Subramaniam, N., Dodermaide, J., Bassett, M. and Powell, L. (2006). The clinical relevance of compound heterozygosity for the haemochromatosis mutations (C282Y/H63D). Digestive Disease Week Meeting/107th Annual Meeting of the American Gastroenterlogical Association, Los Angeles, CA, United States, 20-25 May 2006. PHILADELPHIA: W.B. Saunders.

The clinical relevance of compound heterozygosity for the haemochromatosis mutations (C282Y/H63D)

2005

Conference Publication

Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.

Powell, LW, Dixon, JL, Anderson, GA, Subramaniam, VN, Lincoln, DJ, Fletcher, LM, Crawford, DH, Searle, JW and Ramm, GA (2005). Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.. 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco CA, NOV 11-15, 2005. HOBOKEN: JOHN WILEY & SONS INC.

Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.

2005

Conference Publication

Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease

Anderson, Greg, Frazer, David M., Bridle, Kim R., Macdonald, Graeme A., Smith, Jeffrey L., Turlin, Bruno, Subramaniam, Nathan, Crawford, Darrell H., Powell, Lawrie W. and Ramm, Grant A. (2005). Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease. 47th Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, 10-13 December, 2005. Washington, D.C., USA: American Society of Hematology.

Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease

2004

Conference Publication

The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screening

Powell, L. W., Dixon, J. L., Ramm, G. A., Anderson, G. J., Subramaniam, V. N., Purdie, D. M., Hewett, D. G., Searle, J. W., Fletcher, L. M., Crawford, D. H., Rodgers, H., Khoo, T. L., Cavanaugh, J. A. and Bassett, M. L. (2004). The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screening. 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston MA, 29 October - 2 November 2004. HOBOKEN: JOHN WILEY & SONS INC.

The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screening

2003

Conference Publication

Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance

Powell, L. W., Dixon, J. L., Hewett, D. G., Purdie, D. M., Ramm, G. A., Anderson, G. J., Subramaniam, N., Fletcher, L. M., Crawford, D. H., Cavanaugh, J. A. and Bassett, M. L. (2003). Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance. 54th Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, United States, 24-28 October 2003. PHILADELPHIA: W B SAUNDERS CO.

Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance

2003

Conference Publication

Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasis

Bridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Millard, K. N., Crawford, D. H. G., Subramaniam, V. N., Powell, L. W., Anderson, G. J. and Ramm , G. A. (2003). Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasis. Australian Gastroenterology Week, Cairns, Australia, 7-10 October 2003. Carlton South, Vic., Australia: Blackwell Publishing Asia. doi: 10.1046/j.1440-1746.18.s2.5.x

Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasis

2003

Conference Publication

The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D)

Hewett, D. G.., Dixon, J. L., Purdie, D. M., Ramm, G. A., Anderson, G. J., Subramaniam, N., Fletcher, L. M., Crawford, D. H., Cavanaugh, J. A., Bassett, M. L. and Powell, L. W. (2003). The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D). 54th Annual Meeting of the American Association for the Study of Liver Disease, Boston, M.A. USA, 24-28 October 2003. PHILADELPHIA: W B SAUNDERS CO.

The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D)

2002

Conference Publication

Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.

Powell, L, Dixon, JL, Ramm, G, Anderson, G, Subramaniam, N, Fletcher, L, Crawford, D, Cavanaugh, J and Bassett, M (2002). Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.. 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), Boston Massachusetts, Nov 01-05, 2002. PHILADELPHIA: W B SAUNDERS CO.

Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.

2002

Conference Publication

Molecular and cellular characterization of transferrin receptor 2

Subramaniam, V. N., Summerville, L. and Wallace, D. F. (2002). Molecular and cellular characterization of transferrin receptor 2. Meeting of the Cell and Molecular Biology of Membrane Transport Systems and Disorders Conference, Coolangatta, Qld, Australia, 2-5 September 2001. TOTOWA: HUMANA PRESS INC. doi: 10.1385/CBB:36:2-3:235

Molecular and cellular characterization of transferrin receptor 2

2001

Conference Publication

Non-HFE related haemochromatosis in Australia

Wallace, D. F., Dixon, J. L., Stephenson, P., Searle, J. W., Fletcher, L. M., Crawford, D. H., Subramaniam, V. N. and Powell, L. W. (2001). Non-HFE related haemochromatosis in Australia. 52th Annual Meeting of the American Association for the Study of Liver Diseases, Dallas, TX, United States, 9-13 November 2001. Hoboken, NJ, United States: John Wiley & Sons.

Non-HFE related haemochromatosis in Australia

1999

Conference Publication

Role or p97 and syntaxin 5 in the assembly of transitional endoplasmic reticulum.

Paiement, J, Roy, L, Hendriks, R, Lavoie, C, Gushue, J, Chever, E, Pelletier, A, Morre, DJ, Subramaniam, VN, Hong, WJ and Bergeron, J (1999). Role or p97 and syntaxin 5 in the assembly of transitional endoplasmic reticulum.. BETHESDA: AMER SOC CELL BIOLOGY.

Role or p97 and syntaxin 5 in the assembly of transitional endoplasmic reticulum.

1998

Conference Publication

Identification and characterization of mbet3.

Loh, E, Subramaniam, VN and Hong, WJ (1998). Identification and characterization of mbet3.. BETHESDA: AMER SOC CELL BIOLOGY.

Identification and characterization of mbet3.

1998

Conference Publication

A novel SNARE protein may involved in Golgi trafficking.

Xu, Y, Wong, SH, Tang, BL, Subramaniam, NV, Zhang, T and Hong, WJ (1998). A novel SNARE protein may involved in Golgi trafficking.. BETHESDA: AMER SOC CELL BIOLOGY.

A novel SNARE protein may involved in Golgi trafficking.

1996

Conference Publication

YP26, a 26 KDA protein potentially involved in ER-Golgi transport in the yeast S-cerevisiae.

Coe, JGS, Subramaniam, VN and Hong, WJ (1996). YP26, a 26 KDA protein potentially involved in ER-Golgi transport in the yeast S-cerevisiae.. BETHESDA: AMER SOC CELL BIOLOGY.

YP26, a 26 KDA protein potentially involved in ER-Golgi transport in the yeast S-cerevisiae.

1996

Conference Publication

alpha-SNAP is required for ER-Golgi transport after vesicle budding but before the docking step

Peter, F, Subramaniam, VN and Hong, WJ (1996). alpha-SNAP is required for ER-Golgi transport after vesicle budding but before the docking step. BETHESDA: AMER SOC CELL BIOLOGY.

alpha-SNAP is required for ER-Golgi transport after vesicle budding but before the docking step

1992

Conference Publication

Identification and characterization of a 28-Kda golgi protein

Subramaniam, V. N. and Hong, W. (1992). Identification and characterization of a 28-Kda golgi protein. unknown, unknown, unknown. Bethesda, MD, United States: American Society for Cell Biology.

Identification and characterization of a 28-Kda golgi protein